Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hewlett Packard Enterprise Co (HPE) vs McKesson Corporation (MCK) Price & Performance

Hewlett Packard Enterprise CoTrade
McKesson CorporationTrade

Price performance (Past 24H)

Key statistics

Hewlett Packard Enterprise Co vs McKesson Corporation — how do they compare? Hewlett Packard Enterprise Co trades at $60.21 (market cap $77.85B), while McKesson Corporation trades at $859.26 (market cap $102.45B). The key difference: McKesson Corporation is the larger of the two by market cap, and Hewlett Packard Enterprise Co pays the higher dividend (0.97%). Which is the better fit depends on your goals.

HPEMCK
Market Cap
$77.85B$102.45B
Sector
TechnologyHealth
52-Week High
$59.83$995.69
52-Week Low
$20.01$671.19
Enterprise Value
$93.80B$108.99B
Dividend Yield
0.97%0.43%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hewlett Packard Enterprise Co

HPE stock trades at $59.83, up 10.03% in 24 hours and near its 52-week high, driven by strong AI infrastructure demand and a Morgan Stanley upgrade. The stock shows bullish technical signals with moving averages supporting upward momentum, though RSI indicates overbought conditions. Recent quarters have consistently beaten EPS estimates, with Q1 2026 EPS at $0.79 versus $0.535 expected. Revenue grew to $34.30 billion in 2025, but net income fell sharply to $57 million due to high investing cash outflows.

Outlook remains positive with a consensus price target of $69.81 (16.7% upside), supported by AI server growth and the Juniper acquisition. Risks include elevated P/E of 54.94, debt-to-asset ratio rising to 29.48%, and volatile cash flows. Investors should weigh robust analyst buy ratings (46%) against profitability pressures and integration challenges from recent deals.

McKesson Corporation

McKesson (MCK) trades at $856.69, down 5.0% over the past day, amid a generally positive fundamental backdrop. The stock shows strong technical support near $851-$870 with bullish moving average signals. Recent Q1 2027 earnings beat expectations with EPS of $9.93 versus $9.56 expected, driven by specialty drug and oncology growth, prompting the company to raise full-year guidance. Revenue reached $359.05 billion in 2025 with net income of $3.30 billion, though margins remain thin at 1.12%.

The outlook remains favorable with 80% analyst buy ratings and a consensus price target of $990.67, suggesting 15.6% upside. Key risks include competitive pressures in pharmaceutical distribution and reliance on specialty drug trends. Cash flow trends improved significantly in 2025 with net cash flow of $1.37 billion, supporting dividend payments and operational flexibility.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Hewlett Packard Enterprise Co

Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment.

Read more on HPE

About McKesson Corporation

McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Read more on MCK